Evidence map›Paper›PMID 29568374›Full record

ArticleOncotarget2018

An open label trial of folate receptor-targeted intraoperative molecular imaging to localize pulmonary squamous cell carcinomas.

Jarrod D Predina, Andrew D Newton, Leilei Xia, Christopher Corbett, Courtney Connolly, Michael Shin, Lydia Frezel Sulyok, Leslie Litzky, Charuhas Deshpande, Shuming Nie and 3 more

Registry-linked trialOpen access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02602119 (Intraoperative Imaging of Pulmonary Nodules by OTL38), which is not on this map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02602119 phase1completednot on this map

Intraoperative Imaging of Pulmonary Nodules by OTL38

TypeinterventionalSponsorUniversity of PennsylvaniaRan2015 to 2022Enrolled262ConditionsNeoplasmsArmsOTL38
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 41 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Targeted optical fluorescence imaging: a meta-narrative review and future perspectives.European journal of nuclear medicine and molecular imaging · 2021
    Review
  14. Review
  15. Review
  16. Fluorescence Image-Guided Surgery - a Perspective on Contrast Agent Development.Proceedings of SPIE--the International Society for Optical Engineering · 2020
    Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Jarrod D PredinaCenter for Precision Surgery, Perelman School of Medicine at The University of Pennsylvania, Philadelphia, PA, USA.
Andrew D NewtonCenter for Precision Surgery, Perelman School of Medicine at The University of Pennsylvania, Philadelphia, PA, USA.
Leilei XiaCenter for Precision Surgery, Perelman School of Medicine at The University of Pennsylvania, Philadelphia, PA, USA.
Christopher CorbettCenter for Precision Surgery, Perelman School of Medicine at The University of Pennsylvania, Philadelphia, PA, USA.
Courtney ConnollyCenter for Precision Surgery, Perelman School of Medicine at The University of Pennsylvania, Philadelphia, PA, USA.
Michael ShinCenter for Precision Surgery, Perelman School of Medicine at The University of Pennsylvania, Philadelphia, PA, USA.
Lydia Frezel SulyokCenter for Precision Surgery, Perelman School of Medicine at The University of Pennsylvania, Philadelphia, PA, USA.
Leslie LitzkyPathology and Laboratory Medicine at The Hospital of The University of Pennsylvania, Philadelphia, PA, USA.
Charuhas DeshpandePathology and Laboratory Medicine at The Hospital of The University of Pennsylvania, Philadelphia, PA, USA.
Shuming NieDepartment Biomedical Engineering and Winship Cancer Institute, Emory University, Atlanta, GA, USA.
Sumith A KularatneDepartment of Chemistry, and Purdue Institute for Drug Discovery, Purdue University, West Lafayette, IN, USA.
Philip S LowDepartment of Chemistry, and Purdue Institute for Drug Discovery, Purdue University, West Lafayette, IN, USA.
Sunil SinghalCenter for Precision Surgery, Perelman School of Medicine at The University of Pennsylvania, Philadelphia, PA, USA.
University of Pennsylvania · USHospital of the University of Pennsylvania · USPurdue University West Lafayette · USEmory University · US

Funding

Near infrared intraoperative molecular imaging of lung adenocarcinomaR01CA193556 · NCI · UNIVERSITY OF PENNSYLVANIA · PI LOW, PHILIP STEWART, SINGHAL, SUNIL · 2016 to 2020
$3.3M
Optimizing Immunotherapy Strategies to Eliminate Recurrences after Cancer SurgeryF32CA210409 · NCI · UNIVERSITY OF PENNSYLVANIA · PI PREDINA, JARROD D · 2016 to 2017
$132k
NCI NIH HHS F32 CA210409NCI NIH HHS R01 CA193556
6 · The paper itself

Abstract

backgroundClinical applicability of folate receptor-targeted intraoperative molecular imaging (FR-IMI) has been established for surgically resectable pulmonary adenocarcinoma. A role for FR-IMI in other lung cancer histologies has not been studied. In this study, we evaluate feasibility of FR-IMI in patients undergoing pulmonary resection for squamous cell carcinomas (SCCs).

methodsIn a human clinical trial (NCT02602119), twelve subjects with pulmonary SCCs underwent FR-IMI with a near-infrared contrast agent that targets the folate receptor-α (FRα), OTL38. Near-infrared signal from tumors and benign lung was quantified to calculate tumor-to-background ratios (TBR). Folate receptor-alpha expression was characterized, and histopathologic correlative analyses were performed to evaluate patterns of OTL38 accumulation. An exploratory analysis was performed to determine patient and histopathologic variables that predict tumor fluorescence.

results9 of 13 SCCs (in 9 of 12 of subjects) displayed intraoperative fluorescence upon NIR evaluation (median TBR, 3.9). OTL38 accumulated within SCCs in a FRα-dependent manner. FR-IMI was reliable in localizing nodules as small as 1.1 cm, and prevented conversion to thoracotomy for nodule localization in three subjects. Upon evaluation of patient and histopathologic variables,

conclusionsThis work demonstrates that FR-IMI is potentially feasible in 70% of SCC patients, and that molecular imaging can improve localization during minimally invasive pulmonary resection. These findings complement previous data demonstrating that ∼98% of pulmonary adenocarcinomas are localized during FR-IMI and suggest broad applicability for NSCLC patients undergoing resection.

Indexed as

folate receptormolecular imagingsquamous cell carcinomasurgery

Identifiers

PMID29568374
PMCPMC5862595
OpenAlexW2792240519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.